These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 18844268

  • 21. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
    Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D.
    Cancer; 2006 Jan 01; 106(1):163-71. PubMed ID: 16331596
    [Abstract] [Full Text] [Related]

  • 22. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, Guerry D.
    J Clin Oncol; 2007 Mar 20; 25(9):1129-34. PubMed ID: 17369575
    [Abstract] [Full Text] [Related]

  • 23. Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients.
    Ponti G, Pollio A, Cesinaro AM, Pellacani G, Magnoni C, Seidenari S.
    Cancer Epidemiol; 2012 Jun 20; 36(3):303-5. PubMed ID: 22153914
    [Abstract] [Full Text] [Related]

  • 24. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO, Yeh JJ, Frank J, Long P, Deal AM, Amos KD, Ollila DW.
    Ann Surg Oncol; 2009 Apr 20; 16(4):941-7. PubMed ID: 19101766
    [Abstract] [Full Text] [Related]

  • 25. Adverse outcomes associated with noncompliance with melanoma treatment guidelines.
    Erickson Foster J, Velasco JM, Hieken TJ.
    Ann Surg Oncol; 2008 Sep 20; 15(9):2395-402. PubMed ID: 18600380
    [Abstract] [Full Text] [Related]

  • 26. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
    Orfaniotis G, Mennie JC, Fairbairn N, Butterworth M.
    J Plast Reconstr Aesthet Surg; 2012 Sep 20; 65(9):1216-9. PubMed ID: 22525255
    [Abstract] [Full Text] [Related]

  • 27. [Pregnancy after malignant melanoma. A follow-up of 23 patients].
    Bork K, Bräuninger W, Czarnetzki BM, Addicks B, Paul E, Glitsch M, Noack C.
    Dtsch Med Wochenschr; 1985 Aug 30; 110(35):1323-7. PubMed ID: 4028986
    [Abstract] [Full Text] [Related]

  • 28. [Clinical characteristics of melanoma metastasis].
    Somlai B.
    Magy Onkol; 2003 Aug 30; 47(1):85-8. PubMed ID: 12704460
    [Abstract] [Full Text] [Related]

  • 29. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases.
    Chen JY, Hruby G, Scolyer RA, Murali R, Hong A, Fitzgerald P, Pham TT, Quinn MJ, Thompson JF.
    Cancer; 2008 Nov 15; 113(10):2770-8. PubMed ID: 18823042
    [Abstract] [Full Text] [Related]

  • 30. [Late recurrence of malignant tumours 20 years after diagnosis and treatment].
    Chodorowski Z, Sein Anand J, Jassem J, Kopacz A, Kruszewski W, Emerich J, Senkus-Konefka E.
    Przegl Lek; 2007 Nov 15; 64(4-5):372-3. PubMed ID: 17724919
    [Abstract] [Full Text] [Related]

  • 31. Melanoma: the management of local recurrence and in-transit metastasis.
    Couture J.
    Can J Surg; 1982 Nov 15; 25(6):698-700. PubMed ID: 7139431
    [Abstract] [Full Text] [Related]

  • 32. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 15; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 33. Can late recurrence of melanoma be predicted at the time of primary treatment.
    Khanna AK, Laidler P, Hughes LE.
    Eur J Surg Oncol; 1986 Mar 15; 12(1):9-12. PubMed ID: 3956758
    [Abstract] [Full Text] [Related]

  • 34. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma.
    Spitler LE, Weber RW, Allen RE, Meyer J, Cruickshank S, Garbe E, Lin HY, Soong SJ.
    J Immunother; 2009 Mar 15; 32(6):632-7. PubMed ID: 19483646
    [Abstract] [Full Text] [Related]

  • 35. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR, Moore D, Kim C, Kashani-Sabet M, Venna SS, Wang W, Boasberg P, O'Day S.
    Oncologist; 2009 Oct 15; 14(10):995-1002. PubMed ID: 19776094
    [Abstract] [Full Text] [Related]

  • 36. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A, Lebwohl M.
    Int J Dermatol; 2007 Jun 15; 46(6):575-7. PubMed ID: 17550554
    [Abstract] [Full Text] [Related]

  • 37. Dermatomyositis associated with malignant melanoma--a marker of poor prognosis?
    Schiller M, Böhm M, Hensen P, Riemann H, Luger TA, Nashan D.
    J Am Acad Dermatol; 2006 Feb 15; 54(2):221-6. PubMed ID: 16443051
    [Abstract] [Full Text] [Related]

  • 38. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
    Garbe C, Ellwanger U, Tronnier M, Brocker EB, Orfanos CE.
    Cancer; 2002 Apr 15; 94(8):2305-7. PubMed ID: 12001131
    [No Abstract] [Full Text] [Related]

  • 39. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
    Ross MI.
    Surg Oncol Clin N Am; 2006 Apr 15; 15(2):341-52. PubMed ID: 16632219
    [Abstract] [Full Text] [Related]

  • 40. The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 Years.
    Deckers EA, Hoekstra-Weebers JEHM, Damude S, Francken AB, Ter Meulen S, Bastiaannet E, Hoekstra HJ.
    Ann Surg Oncol; 2020 May 15; 27(5):1407-1417. PubMed ID: 31535302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.